{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:27:54Z","timestamp":1787020074744,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT087546MA"],"award-info":[{"award-number":["WT087546MA"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Tuberculosis (TB), particularly multi- and or extensive drug resistant TB, is still a global medical emergency. Whole genome sequencing (WGS) is a current alternative to the WHO-approved probe-based methods for TB diagnosis and detection of drug resistance, genetic diversity and transmission dynamics of\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      complex (MTBC). This study compared WGS and clinical data in participants with TB.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This cohort study performed WGS on 87 from MTBC DNA isolates, 57 (66%) and 30 (34%) patients with drug resistant and susceptible TB, respectively. Drug resistance was determined by Xpert\u00ae MTB\/RIF assay and phenotypic culture-based drug-susceptibility-testing (DST). WGS and bioinformatics data that predict phenotypic resistance to anti-TB drugs were compared with participant\u2019s clinical outcomes. They were 47 female participants (54%) and the median age was 35\u2009years (IQR): 29\u201344). Twenty (23%) and 26 (30%) of participants had TB\/HIV co-infection BMI\u2009&lt;\u200918\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      respectively. MDR-TB participants had MTBC with multiple mutant genes, compared to those with mono or polyresistant TB, and the majority belonged to lineage 3 Central Asian Strain (CAS). Also, MDR-TB was associated with delayed culture-conversion (median: IQR (83: 60\u2013180 vs. 51:30\u201366) days). WGS had high concordance with both culture-based DST and Xpert\u00ae MTB\/RIF assay in detecting drug resistance (kappa\u2009=\u20091.00).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study offers comparison of mutations detected by Xpert and WGS with phenotypic DST of\n                      <jats:italic>M. tuberculosis<\/jats:italic>\n                      isolates in Tanzania. The high concordance between the different methods and further insights provided by WGS such as PZA-DST, which is not routinely performed in most resource-limited-settings, provides an avenue for inclusion of WGS into diagnostic matrix of TB including drug-resistant TB.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12864-020-6577-1","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T10:02:44Z","timestamp":1582279364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania"],"prefix":"10.1186","volume":"21","author":[{"given":"Bugwesa Z.","family":"Katale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Mbelele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nsiande A.","family":"Lema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Campino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Mshana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Rweyemamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody E.","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius D.","family":"Keyyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mtebe","family":"Majigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erasto V.","family":"Mbugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel M.","family":"Dockrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taane G.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6900-1533","authenticated-orcid":false,"given":"Mecky I.","family":"Matee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stellah","family":"Mpagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"6577_CR1","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.4081\/idr.2016.6570","volume":"8","author":"M Raviglione","year":"2016","unstructured":"Raviglione M, Sulis G. Tuberculosis 2015: burden, challenges and strategy for control and elimination. Infectious disease reports. 2016;8:6570.","journal-title":"Infectious disease reports"},{"key":"6577_CR2","unstructured":"W.H.O. Global Tuberculosis Report 2017. World Health Organization 2017."},{"key":"6577_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/828939","volume":"2013","author":"Padmanesan Narasimhan","year":"2013","unstructured":"Narasimhan, P., Wood, J., MacIntyre, C. R & Mathai, D. 2013. Risk Factors for Tuberculosis. Pulm Med V 2013, Article ID 828939, 11 pages. http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1155\/2013\/828939","journal-title":"Pulmonary Medicine"},{"key":"6577_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1874613601610010034","volume":"10","author":"ABM Kharsany","year":"2016","unstructured":"Kharsany ABM, Karim QA. HIV infection and AIDS in sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016;10:34\u201348.","journal-title":"Open AIDS J"},{"key":"6577_CR5","unstructured":"W.H.O. World Tuberculosis DAY 2019. https:\/\/www.afro.who.int\/media-centre\/events\/world-tuberculosis-day-2019."},{"issue":"2","key":"6577_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1183\/13993003.00543-2016","volume":"48","author":"H Albert","year":"2016","unstructured":"Albert H, Nathavitharana RR, Isaacs C, Pai M, Denkinger CM, Boehme CC, C.C. Development, roll-out and impact of Xpert MTB\/RIF for tuberculosis: what lessons have we learnt and how can we do better? Eur Respir J. 2016;48(2):516\u201325.","journal-title":"Eur Respir J"},{"issue":"9","key":"6577_CR7","doi-asserted-by":"publisher","first-page":"e0185105","DOI":"10.1371\/journal.pone.0185105","volume":"12","author":"Baba Maiyaki Musa","year":"2017","unstructured":"Musa, B.M., Adamu A.L., Galadanci, N.A., Zubayr, B., Odoh, C.N., Aliyu, M.H. 2017. Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis. PLoS One 12(9): e0185105. https:\/\/doi.org\/https:\/\/doi.org\/10.1371\/journal.pone.0185105.","journal-title":"PLOS ONE"},{"key":"6577_CR8","unstructured":"Dye, C., Harries, A.D., Maher, D., Mehran Hosseini, S., Nkhoma, W & Salaniponi, F.M. 2006. Disease and mortality in sub-Saharan Africa. 2nd edition. In Jamison DT, Feachem RG, Makgoba MW, Bos, E.R., Baingana, F.K., Hofman, K. J & Rogo, K.O. Washington (DC): the International Bank for Reconstruction and Development \/ the World Bank; 2006. ISBN-10: 0-8213-6397-2, ISBN-13: 978-0-8213-6397-3."},{"key":"6577_CR9","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1056\/NEJM200104263441706","volume":"344","author":"MA Espinal","year":"2001","unstructured":"Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S, Rieder HL, Binkin N, Dye C, Williams R, Raviglione MC. Global trends in resistance to anti-TB drugs. N Engl J Med. 2001;344:1294\u2013303.","journal-title":"N Engl J Med"},{"issue":"8","key":"6577_CR10","first-page":"967","volume":"14","author":"TM Chonde","year":"2010","unstructured":"Chonde TM, Basra D, Mfinanga SGM, Range N, Lwilla F, Shirima RP, van Deun A, Zignol M, Cobelens FG, Egwaga SM, van Leth F. National anti-tuberculosis drug resistance study in Tanzania. IJTLD. 2010;14(8):967\u2013972(6).","journal-title":"IJTLD"},{"key":"6577_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/oxfordjournals.bmb.a011712","volume":"54","author":"JR Glynn","year":"1998","unstructured":"Glynn JR. Resurgence of tuberculosis and the impact of HIV infection. Br Med Bull. 1998;54:579\u201393.","journal-title":"Br Med Bull"},{"key":"6577_CR12","volume-title":"Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis","author":"W.H.O","year":"2014","unstructured":"W.H.O. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization; 2014."},{"key":"6577_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.5588\/ijtld.15.0896","volume":"20","author":"S Foongladda","year":"2016","unstructured":"Foongladda S, Banu S, Pholwat S, Gratz J, O-Thong S, Nakkerd N, Chinli R, Ferdous SS, Rahman SMM, Rahman A, Ahmed S, Heysell S, Sariko M, Kibiki G, Houpt E. Comparison of TaqMan\u00ae Array card and MYCOTBTM with conventional phenotypic susceptibility testing in MDR-TB. Int J Tuberc Lung Dis. 2016;20:1105\u201312.","journal-title":"Int J Tuberc Lung Dis"},{"key":"6577_CR14","unstructured":"Chonde TM, Basra D, Mfinanga SG, et al. National anti-tuberculosis drug resistance study in Tanzania. Int J Tuberc Lung Dis. 2010;14(8):967\u201372."},{"key":"6577_CR15","unstructured":"W.H.O. WHO treatment guidelines for drug- resistant tuberculosis 2016. Geneva; 2016."},{"key":"6577_CR16","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1186\/s12879-017-2931-6","volume":"17","author":"PM Mbelele","year":"2017","unstructured":"Mbelele PM, Aboud S, Mpagama SG, Matee MI. Improved performance of Xpert MTB\/RIF assay on sputum sediment samples obtained from presumptive pulmonary tuberculosis cases at Kibong'oto infectious diseases hospital in\u00c2 Tanzania. BMC Infect Dis. 2017;17:808.","journal-title":"BMC Infect Dis"},{"key":"6577_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jgar.2017.09.002","volume":"12","author":"H Karimi","year":"2017","unstructured":"Karimi H, En-Nanai L, Oudghiri A, Chaoui I, Laglaoui A, Bourkadi JE, El Mzibri M, Abid M. Performance of GenoType\u00ae MTBDRplus assay in the diagnosis of drug-resistant tuberculosis in Tangier, Morocco. J Glob Antimicrob Resist. 2017;12:63\u20137.","journal-title":"J Glob Antimicrob Resist"},{"key":"6577_CR18","first-page":"CD010705","volume":"9","author":"G Theron","year":"2016","unstructured":"Theron G, Peter J, Richardson M, Warren R, Dheda K, Steingart KR. GenoType\u00ae MTBDRsl assay for resistance to second-line anti-tuberculosis drugs. The Cochrane database of systematic reviews. 2016;9:CD010705.","journal-title":"The Cochrane database of systematic reviews"},{"key":"6577_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ijid.2016.10.021","volume":"56","author":"G Sotgiu","year":"2017","unstructured":"Sotgiu G, Tiberi S, Centis R, D\u2019Ambrosio L, Fuentes Z, Zumla A, Migliori GB. Applicability of the shorter &#x2018;Bangladesh regimen&#x2019; in high multidrug-resistant tuberculosis settings. Int J Infect Dis. 2017;56:190\u20133.","journal-title":"Int J Infect Dis"},{"key":"6577_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tube.2018.04.003","volume":"110","author":"CS Feliciano","year":"2018","unstructured":"Feliciano CS, Namburete EI, Pla\u00e7a JR, K. Peronni, Dippenaar A, Warren RM, Silva WAJ, Bollela VR. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant mycobacterium tuberculosis isolated from patients in Brazil and Mozambique. Tuberculosis. 2018;110:59\u201367.","journal-title":"Tuberculosis"},{"key":"6577_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.tube.2017.08.002","volume":"107","author":"A Chatterjee","year":"2017","unstructured":"Chatterjee A, Nilgiriwala K, Saranath D, Rodrigues C, Mistry N. Whole genome sequencing of clinical strains of mycobacterium tuberculosis from Mumbai, India: A potential tool for determining drug-resistance and strain lineage. Tuberculosis. 2017;107:63\u201372.","journal-title":"Tuberculosis"},{"key":"6577_CR22","first-page":"e01480","volume":"56","author":"TP Quan","year":"2018","unstructured":"Quan TP, Bawa Z, Foster D, Walker T, Elias CDO, Rathod P, M. M. M. I. Group, Iqbal Z, Bradley P, Mowbray J, Walker AS, Crook DW, Wyllie DH, Peto TEA, Smith EG. Evaluation of whole-genome sequencing for mycobacterial species identification and drug susceptibility testing in a clinical setting: a large-scale prospective assessment of performance against line probe assays and Phenotyping. J Clin Microbiol. 2018;56:e01480\u201317.","journal-title":"J Clin Microbiol"},{"key":"6577_CR23","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1128\/JCM.00298-17","volume":"55","author":"J Shea","year":"2017","unstructured":"Shea J, Halse TA, Lapierre P, Shudt M, Kohlerschmidt D, Van Roey P, Limberger R, Taylor J, Escuyer V, Musser KA. Comprehensive whole-genome sequencing and reporting of drug resistance profiles on clinical cases of mycobacterium tuberculosis in New York state. J Clin Microbiol. 2017;55:1871\u201382.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"6577_CR24","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1473-3099(15)00062-6","volume":"15","author":"Timothy M Walker","year":"2015","unstructured":"Walker, T. M., T. A. Kohl, S. V. Omar, J. Hedge, C. Del Ojo Elias, P. Bradley, Z. Iqbal, S. Feuerriegel, K. E. Niehaus, D. J. Wilson, D. A. Clifton, G. Kapatai, C. L. C. Ip, R. Bowden, F. A. Drobniewski, C. Allix-B\u00c3\u00a9guec, C. Gaudin, J. Parkhill, R. Diel, P. Supply, D. W. Crook, E. G. Smith, A. S. Walker, N. Ismail, S. Niemann, T. E. A. Peto, and G. Modernizing Medical Microbiology Informatics. 2015. Whole-genome sequencing for prediction of mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 15:1193\u20131202.","journal-title":"The Lancet Infectious Diseases"},{"key":"6577_CR25","doi-asserted-by":"publisher","first-page":"25330","DOI":"10.1038\/srep25330","volume":"6","author":"Y Pang","year":"2016","unstructured":"Pang Y, Dong H, Tan Y, Deng Y, Cai X, Jing H, Xia H, Li Q, Ou X, Su B, Li X, Zhang Z, Li J, Zhang J, Huan S, Zhao Y. Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China. Sci Rep. 2016;6:25330.","journal-title":"Sci Rep"},{"key":"6577_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/INF.0000000000002040","volume":"37","author":"MA Shah","year":"2018","unstructured":"Shah MA, Shah I. Increasing prevalence of pediatric drug-resistant tuberculosis in Mumbai, India, and its outcome. Pediatr Infect Dis J. 2018;37:1261\u20133.","journal-title":"Pediatr Infect Dis J"},{"key":"6577_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12879-017-2409-6","volume":"17","author":"J Chen","year":"2017","unstructured":"Chen J, Peng P, Du Y, Ren Y, Chen L, Rao Y, Wang W. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing. BMC Infect Dis. 2017;17:300.","journal-title":"BMC Infect Dis"},{"key":"6577_CR28","doi-asserted-by":"publisher","first-page":"1701354","DOI":"10.1183\/13993003.01354-2017","volume":"50","author":"P Miotto","year":"2017","unstructured":"Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM, Emerson C, Hanna D, Kim PS, Liwski R, Zignol M, Gilpin C, Niemann S, Denkinger CM, Fleming J, Warren RM, Crook D, Posey J, Gagneux S, Hoffner S, Rodrigues C, Comas IA, Engelthaler DM, Murray M, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, Ranganathan UDK, McNerney R, Ezewudo M, Cirillo DM, Schito M, K\u00c3ser CU, Rodwell TC. A standardised method for interpreting the association between mutations and phenotypic drug resistance in mycobacterium tuberculosis. Eur Respir J. 2017;50:1701354.","journal-title":"Eur Respir J"},{"key":"6577_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4103\/ijmy.ijmy_135_18","volume":"7","author":"P Mbelele","year":"2018","unstructured":"Mbelele P, Mohamed S, Sauli E, Mpolya E, Mfinanga S, Addo K, Heysell S, Mpagama S. Meta-narrative review of molecular methods for diagnosis and monitoring of multidrug-resistant tuberculosis treatment in adults. International Journal of Mycobacteriology. 2018;7:299\u2013309.","journal-title":"International Journal of Mycobacteriology"},{"key":"6577_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cmi.2016.09.008","volume":"23","author":"D Papaventsis","year":"2017","unstructured":"Papaventsis D, Casali N, Kontsevaya I, Drobniewski F, Cirillo DM, Nikolayevskyy V. Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review. Clin Microbiol Infect. 2017;23:61\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"6577_CR31","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1128\/JCM.02993-14","volume":"53","author":"AA Witney","year":"2015","unstructured":"Witney AA, Gould KA, Arnold A, Coleman D, Delgado R, Dhillon J, Pond MJ, Pope CF, Planche TD, Stoker NG, Cosgrove CA, Butcher PD, Harrison TS, Hinds J. Clinical application of whole-genome sequencing to inform treatment for multidrug-resistant tuberculosis cases. J Clin Microbiol. 2015;53:1473\u201383.","journal-title":"J Clin Microbiol"},{"key":"6577_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijid.2016.11.422","volume":"56","author":"R McNerney","year":"2017","unstructured":"McNerney R, Clark TG, Campino S, Rodrigues C, Dolinger D, Smith L, Cabibbe AM, Dheda K, Schito M. Removing the bottleneck in whole genome sequencing of mycobacterium tuberculosis for rapid drug resistance analysis: a call to action. Int J Infect Dis. 2017;56:130\u20135.","journal-title":"Int J Infect Dis"},{"key":"6577_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12916-016-0598-2","volume":"14","author":"AA Witney","year":"2016","unstructured":"Witney AA, Cosgrove CA, Arnold A, Hinds J, Stoker NG, Butcher PD. Clinical use of whole genome sequencing for mycobacterium tuberculosis. BMC Med. 2016;14:46.","journal-title":"BMC Med"},{"key":"6577_CR34","volume-title":"Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis","author":"WHO Rapid Communication","year":"2018","unstructured":"Rapid Communication WHO. Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis. Geneva: World Health Organisation; 2018."},{"key":"6577_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12916-016-0575-9","volume":"14","author":"J Phelan","year":"2016","unstructured":"Phelan J, Coll F, McNerney R, Ascher DB, Pires DEV, Furnham N, Coeck N, Hill-Cawthorne GA, Nair MB, Mallard K, Ramsay A, Campino S, Hibberd ML, Pain A, Rigouts L, Clark TG. Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance. BMC Med. 2016;14:31.","journal-title":"BMC Med"},{"key":"6577_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.meegid.2016.02.019","volume":"40","author":"W Ssengooba","year":"2016","unstructured":"Ssengooba W, Meehan CJ, Lukoye D, Kasule GW, Musisi K, Joloba ML, Cobelens FG, de Jong BC. Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda. Infect, Genet Evol : J Molecular epidemiology and evolutionary genetics in infectious diseases. 2016;40:8\u201316.","journal-title":"Infect, Genet Evol : J Molecular epidemiology and evolutionary genetics in infectious diseases"},{"key":"6577_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijid.2015.01.014","volume":"32","author":"JD Fonseca","year":"2015","unstructured":"Fonseca JD, Knight GM, McHugh TD. The complex evolution of antibiotic resistance in <em>mycobacterium tuberculosis<\/em>. Int J Infect Dis. 2015;32:94\u2013100.","journal-title":"Int J Infect Dis"},{"key":"6577_CR38","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00204-016-1727-6","volume":"90","author":"L Nguyen","year":"2016","unstructured":"Nguyen L. Antibiotic resistance mechanisms in M. tuberculosis: an update. Arch Toxicol. 2016;90:1585\u2013604.","journal-title":"Arch Toxicol"},{"key":"6577_CR39","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jac\/dkx506","volume":"73","author":"N Dookie","year":"2018","unstructured":"Dookie N, Rambaran S, Padayatchi N, Mahomed S, Naidoo K. Evolution of drug resistance in mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care. J Antimicrob Chemother. 2018;73:1138\u201351.","journal-title":"J Antimicrob Chemother"},{"key":"6577_CR40","doi-asserted-by":"publisher","first-page":"e0142290","DOI":"10.1371\/journal.pone.0142290","volume":"10","author":"HT Ayele","year":"2015","unstructured":"Ayele HT, van Mourik MS, Debray TP, Bonten MJ. Isoniazid prophylactic therapy for the prevention of tuberculosis in HIV infected adults: A systematic review and meta-analysis of randomized trials. PLoS One. 2015;10:e0142290.","journal-title":"PLoS One"},{"key":"6577_CR41","doi-asserted-by":"publisher","unstructured":"CRyPTIC Consortium and the 100,000 Genomes Project, Allix-B\u00e9guec C, Arandjelovic I, et al. Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. N Engl J Med. 2018;379(15):1403\u201315. https:\/\/doi.org\/10.1056\/NEJMoa1800474.","DOI":"10.1056\/NEJMoa1800474"},{"key":"6577_CR42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/ijcm.IJCM_152_17","volume":"43","author":"SV Patel","year":"2018","unstructured":"Patel SV, Nimavat KB, Patel AB, Mehta KG, Shringarpure K, Shukla LK. Sputum smear and culture conversion in multidrug resistance tuberculosis patients in seven districts of Central Gujarat, India: A longitudinal study. Indian J Commun Med : Official Publication Indian Assoc Prev Soc Med. 2018;43:117\u20139.","journal-title":"Indian J Commun Med : Official Publication Indian Assoc Prev Soc Med"},{"key":"6577_CR43","doi-asserted-by":"publisher","first-page":"e0198080","DOI":"10.1371\/journal.pone.0198080","volume":"13","author":"A Shibabaw","year":"2018","unstructured":"Shibabaw A, Gelaw B, Wang S-H, Tessema B. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia. PLoS One. 2018;13:e0198080.","journal-title":"PLoS One"},{"key":"6577_CR44","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/thoraxjnl-2015-207374","volume":"70","author":"D Meressa","year":"2015","unstructured":"Meressa D, Hurtado RM, Andrews JR, Diro E, Abato K, Daniel T, Prasad P, Prasad R, Fekade B, Tedla Y, Yusuf H, Tadesse M, Tefera D, Ashenafi A, Desta G, Aderaye G, Olson K, Thim S, Goldfeld AE. Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia\u00e2\u20ac an observational cohort study. Thorax. 2015;70:1181\u20138.","journal-title":"Thorax"},{"key":"6577_CR45","unstructured":"W.H.O. The END TB Strategy 2015\u20132035 [Internet]. Geneva: World Health Organization; 2015. Available from:http:\/\/www.who.int\/tb\/End_TB_brochure.pdf."},{"key":"6577_CR46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S2213-2600(16)30433-7","volume":"5","author":"K Dheda","year":"2017","unstructured":"Dheda K, Limberis JD, Pietersen E, Phelan J, Esmail A, Lesosky M, Fennelly KP, te Riele J, Mastrapa B, Streicher EM, Dolby T, Abdallah AM, Ben-Rached F, Simpson J, Smith L, Gumbo T, van Helden P, Sirgel FA, McNerney R, Theron G, Pain A, Clark TG, Warren RM. Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study. Lancet Respir Med. 2017;5:269\u201381.","journal-title":"Lancet Respir Med"},{"key":"6577_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijmyco.2015.03.005","volume":"4","author":"V Milanov","year":"2015","unstructured":"Milanov V, Falzon D, Zamfirova M, Varleva T, Bachiyska E, Koleva A, Dara M. Factors associated with treatment success and death in cases with multidrug-resistant tuberculosis in Bulgaria, 2009-2010. Int J Mycobacteriol. 2015;4:131\u20137.","journal-title":"Int J Mycobacteriol"},{"key":"6577_CR48","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12879-015-1214-3","volume":"15","author":"T Umanah","year":"2015","unstructured":"Umanah T, Ncayiyana J, Padanilam X, Nyasulu PS. Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus co-infected patients on anti-retroviral therapy at Sizwe tropical disease hospital Johannesburg, South Africa. BMC Infect Dis. 2015;15:478.","journal-title":"BMC Infect Dis"},{"key":"6577_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tube.2018.02.004","volume":"109","author":"BR Kidenya","year":"2018","unstructured":"Kidenya BR, Mshana SE, Fitzgerald DW, Ocheretina O. Genotypic drug resistance using whole-genome sequencing of mycobacterium tuberculosis clinical isolates from North-Western Tanzania. Tuberculosis. 2018;109:97\u2013101.","journal-title":"Tuberculosis"},{"key":"6577_CR50","unstructured":"World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis. 2016 update WHO\/HTM\/TB\/2016.04. Geneva: World Health Organization; 2016. Available from: www.who.int\/tb\/MDRTBguidelines2016.pdf."},{"key":"6577_CR51","doi-asserted-by":"publisher","first-page":"238532","DOI":"10.1155\/2014\/238532","volume":"2014","author":"M Belay","year":"2014","unstructured":"Belay M, Ameni G, Bjune G, Couvin D, Rastogi N, Abebe F. Strain diversity of mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Afar pastoral region of Ethiopia. Biomed Res Int. 2014;2014:238532.","journal-title":"Biomed Res Int"},{"key":"6577_CR52","doi-asserted-by":"publisher","first-page":"e0154571","DOI":"10.1371\/journal.pone.0154571","volume":"11","author":"EV Mbugi","year":"2016","unstructured":"Mbugi EV, Katale BZ, Streicher EM, Keyyu JD, Kendall SL, Dockrell HM, Michel AL, Rweyemamu MM, Warren RM, Matee MI, van Helden PD, Couvin D, Rastogi N. Mapping of mycobacterium tuberculosis complex genetic diversity profiles in Tanzania and other African countries. PLoS One. 2016;11:e0154571.","journal-title":"PLoS One"},{"key":"6577_CR53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1471-2458-8-68","volume":"8","author":"M Matee","year":"2008","unstructured":"Matee M, Mtei L, Lounasvaara T, Wieland-Alter W, Waddell R, Lyimo J, Bakari M, Pallangyo K, von Reyn CF. Sputum microscopy for the diagnosis of HIV-associated pulmonary tuberculosis in Tanzania. BMC Public Health. 2008;8:68.","journal-title":"BMC Public Health"},{"key":"6577_CR54","first-page":"623","volume":"45","author":"SG Yurtsever","year":"2011","unstructured":"Yurtsever SG, Bicmen C, G\u00fcnd\u00fcz AT, Ozkutuk N, Salman S, Demirci M. Comparison of proportion method in L\u00f6wenstein-Jensen medium with the BACTEC 460 TB system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis isolates. Microbiol Bulletin. 2011;45:623\u201331.","journal-title":"Microbiol Bulletin"},{"key":"6577_CR55","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1128\/JCM.29.11.2578-2586.1991","volume":"29","author":"D van Soolingen","year":"1991","unstructured":"van Soolingen D, Hermans PW, de Haas PE, Soll DR, van Embden JD. Occurrence and stability of insertion sequences in mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol. 1991;29:2578\u201386.","journal-title":"J Clin Microbiol"},{"key":"6577_CR56","unstructured":"Li, H. 2013. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Quantitative biology > genomics (submitted on 16 mar 2013 (v1), last revised 26 may 2013 (this version, v2)."},{"key":"6577_CR57","doi-asserted-by":"publisher","first-page":"11189","DOI":"10.1093\/nar\/gks918","volume":"40","author":"A Wilm","year":"2012","unstructured":"Wilm A, Aw PPK, Bertrand D, Yeo GHT, Ong SH, Wong CH, Khor CC, Petric R, Hibberd ML, Nagarajan N. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res. 2012;40:11189\u2013201.","journal-title":"Nucleic Acids Res"},{"key":"6577_CR58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13073-015-0164-0","volume":"7","author":"F Coll","year":"2015","unstructured":"Coll F, McNerney R, Preston MD, Guerra-Assun\u00e7\u00e3o JA, Warry A, Hill-Cawthorne G, Mallard K, Nair M, Miranda A, Alves A, Perdig\u00e3o J, Viveiros M, Portugal I, Hasan Z, Hasan R, Glynn JR, Martin N, Pain A, Clark TG. Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. Genome Medicine. 2015;7:51.","journal-title":"Genome Medicine"},{"key":"6577_CR59","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1093\/bioinformatics\/btr509","volume":"27","author":"H Li","year":"2011","unstructured":"Li H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics (Oxford, England). 2011;27:2987\u201393.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"15","key":"6577_CR60","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1093\/bioinformatics\/btv184","volume":"31","author":"Alexey M. Kozlov","year":"2015","unstructured":"Kozlov, A. M., A. J. Aberer, and A. Stamatakis. 2015. ExaML version 3: a tool for phylogenomic analyses on supercomputers. Bioinformatics (Oxford, England) 31:2577-2579.","journal-title":"Bioinformatics"},{"key":"6577_CR61","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1038\/ncomms5812","volume":"5","author":"F Coll","year":"2014","unstructured":"Coll F, McNerney R, Guerra-Assun\u00e7\u00e3o JA, Glynn JR, Perdig\u00e3o J, Viveiros M, Portugal I, Pain A, Martin N, Clark TG. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun. 2014;5:4812.","journal-title":"Nat Commun"},{"key":"6577_CR62","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkw290","volume":"44","author":"I Letunic","year":"2016","unstructured":"Letunic I, Bork P. Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res. 2016;44:W242\u20135.","journal-title":"Nucleic Acids Res"},{"key":"6577_CR63","unstructured":"Ondimu, T. O., M. O. Grace, A. O. Samson, and S. A. Asito. 2017. Comparative study of smear microscopy, GeneXpert and culture and sensitivity assays in detection of mycobacterium tuberculosis on sputum samples among tuberculosis suspected cases in Nyamira County referral hospital. Mycobacterial diseases 7."}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-020-6577-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12864-020-6577-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-020-6577-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T18:45:32Z","timestamp":1722451532000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/s12864-020-6577-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6577"],"URL":"https:\/\/doi.org\/10.1186\/s12864-020-6577-1","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]},"assertion":[{"value":"4 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Senate Research and Publications Committee of the Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania approved the study (Ref. No. MU\/PGS\/PhD\/Vol.VI\/154). Permission to conduct the study was obtained from KIDH administration. Prior to any study procedure, we obtained written informed consent that was signed by all patients. All study participants received MDR-TB treatment according to existing National and global MDR-TB treatment guidelines in Tanzania [\n                      \n                      ,\n                      \n                      ].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest related to this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}